The aim of another pre-clinical study involving both murine and human breast cancer cells was to evaluate the role of hypoxia in elevating PD-L1 expression in triple-negative breast cancer, given the limited understanding of the signalling pathways within tumours involving immune checkpoints. This evidence concerns the gene CD274 and neoplasm.